GIORDANI, ERIKA
 Distribuzione geografica
Continente #
NA - Nord America 329
EU - Europa 137
AS - Asia 71
AF - Africa 4
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 545
Nazione #
US - Stati Uniti d'America 327
SE - Svezia 58
IN - India 31
IT - Italia 30
CN - Cina 27
FI - Finlandia 18
SG - Singapore 12
FR - Francia 7
DE - Germania 6
RO - Romania 6
UA - Ucraina 5
GB - Regno Unito 4
TG - Togo 3
AR - Argentina 2
CA - Canada 2
CH - Svizzera 1
EU - Europa 1
IE - Irlanda 1
LV - Lettonia 1
PE - Perù 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 545
Città #
Ashburn 45
Fairfield 30
Chandler 28
Woodbridge 25
Beijing 21
Wilmington 15
Ann Arbor 13
Plano 13
Cambridge 12
Princeton 12
Seattle 10
Boston 8
Houston 8
San Paolo di Civitate 8
Washington 8
Lawrence 6
Millbury 5
Rome 5
San Diego 5
Dearborn 4
Helsinki 4
Norwalk 4
Lomé 3
Mumbai 3
Andover 2
Federal 2
Florence 2
Fremont 2
Hefei 2
Pune 2
Redwood City 2
Rozzano 2
Singapore 2
Toronto 2
Bangalore 1
Bremen 1
Bühl 1
Chengdu 1
Crocetta del Montello 1
Dossenheim 1
Dublin 1
Fasano 1
Genoa 1
Grafing 1
Guangzhou 1
Hyderabad 1
Jinhua 1
Kunming 1
Leawood 1
Lima 1
Melegnano 1
Monmouth Junction 1
Padova 1
Paris 1
Riga 1
Silverton 1
Silvi 1
Southend 1
Zurich 1
Totale 340
Nome #
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study. 82
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts) 53
An unusual case of spleen metastasis from carcinoma ex pleomorphic adenoma of the parotid gland 51
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 47
null 45
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer 38
Emerging Role of Cetuximab in the Treatment of Colorectal Cancer 35
From conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors 34
null 33
null 29
null 20
Incidence of chemotherapy (CT) induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T) 20
null 18
Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100+/- docetaxel. Comparison of efficacy and tolerability between lenograstim and pegfilgrastim 16
null 15
Radiological and pathological complete response in a young patient locally advanced her2 breast cancer after neoadjuvant treatment with trastuzumab and non-pegylated liposomal doxorubicin (nPLD) 14
Efficacy, safety and cost-effectiveness (ce) analysis of lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer (bc) patients 14
Non pegylated liposomal doxorubicin (npld) in neoadjuvant treatment of local advanced breast cancer (labc) 10
Totale 574
Categoria #
all - tutte 1.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 0 10 5
2019/2020136 26 11 5 5 6 10 14 12 15 15 13 4
2020/202130 5 5 2 3 0 3 0 2 5 4 0 1
2021/2022130 0 1 15 9 21 4 2 13 15 5 19 26
2022/2023139 35 42 13 4 13 11 6 2 7 0 5 1
2023/202481 4 7 12 3 21 25 0 0 2 7 0 0
Totale 574